Curcumin: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
}} | }} | ||
Β Communicated by [[Doerrier C]] (2015-03-03). | Β Communicated by [[Doerrier C]] (2015-03-03). | ||
Β | __TOC__ | ||
== Curcumin and mitObesity == | == Curcumin and mitObesity == | ||
Β ''Work in progress'' by [[Gnaiger E]] 2020- | Β ''Work in progress'' by [[Gnaiger E]] 2020-02-09 linked to a preprint in preparation on [[body mass excess |'''BME''']] and [[:Category:BME and mitObesity |'''mitObesity''']]. | ||
== References: Curcumin == | |||
:::# [[Eckert 2012 Mol Neurobiol]] | :::# [[Eckert 2012 Mol Neurobiol]] | ||
:::# [[Eckert 2013 Neurochem Int]] | :::# [[Eckert 2013 Neurochem Int]] | ||
Line 36: | Line 37: | ||
:::# Li H, Qi J, Li L (2019) Phytochemicals as potential candidates to combat obesity via adipose non-shivering thermogenesis. Pharmacol Res 147:104393. - https://www.ncbi.nlm.nih.gov/pubmed/31401211 | :::# Li H, Qi J, Li L (2019) Phytochemicals as potential candidates to combat obesity via adipose non-shivering thermogenesis. Pharmacol Res 147:104393. - https://www.ncbi.nlm.nih.gov/pubmed/31401211 | ||
{{MitoPedia: mitObesity drugs}} | |||
Β | |||
{{MitoPedia concepts | |||
|mitopedia concept=MiP concept | |||
}} | |||
{{Labeling | |||
|additional=MitoPedia:mitObesity drug | |||
}} |
Revision as of 00:08, 10 February 2020
Description
Curcumin has been shown to possess significant anti-inflammatory, anti-oxidant, anti-carcinogenic, anti-mutagenic, anti-coagulant and anti-infective effects. The protective effects of curcumin on rat heart mitochondrial injuries induced by in vitro anoxiaβreoxygenation were evaluated by Xu et al 2013. It was found that curcumin added before anoxia or immediately prior to reoxygenation exhibited remarkable protective effects against anoxiaβreoxygenation induced oxidative damage to mitochondria.
Reference: Xu et al 2013
Communicated by Doerrier C (2015-03-03).
Curcumin and mitObesity
Work in progress by Gnaiger E 2020-02-09 linked to a preprint in preparation on BME and mitObesity.
References: Curcumin
- Eckert 2012 Mol Neurobiol
- Eckert 2013 Neurochem Int
- Hagl 2014 J Alzheimers Dis b
- Hagl 2015 Neurochem Int
- Hirzel 2013 J Recept Signal Transduct Res
- Kener 2018 J Vis Exp
- Ortega-Dominguez 2017 Food Chem Toxicol
- Tueller 2017 Biochem Biophys Res Commun
- Shehzad A1, Rehman G, Lee YS (2013) Curcumin in inflammatory diseases. Biofactors 39:69-77. - https://www.ncbi.nlm.nih.gov/pubmed/23281076
- Den Hartogh DJ, Gabriel A, Tsiani E (2020) Antidiabetic properties of Curcumin I: Evidence from in vitro studies. Nutrients 12 pii:E118. - https://www.ncbi.nlm.nih.gov/pubmed/31906278
- Den Hartogh DJ, Gabriel A, Tsiani E (2020) Antidiabetic properties of Curcumin II: Evidence from in vivo studies. Nutrients 12 pii:E58. - https://www.ncbi.nlm.nih.gov/pubmed/31881654
- Lee ES, Kwon MH, Kim HM, Woo HB, Ahn CM, Chung CH (2019) Curcumin analog CUR5-8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity. Metabolism 103:154015. - https://www.ncbi.nlm.nih.gov/pubmed/31758951
- Liu Y, Weng W, Gao R, Liu Y (2019) New insights for cellular and molecular mechanisms of aging and aging-related diseases: herbal medicine as potential therapeutic approach. Oxid Med Cell Longev 2019:4598167. - https://www.ncbi.nlm.nih.gov/pubmed/31915506
- Tizabi Y, Getachew B, Csoka AB, Manaye KF, Copeland RL (2019) Novel targets for parkinsonism-depression comorbidity. Prog Mol Biol Transl Sci 167:1-24. - https://www.ncbi.nlm.nih.gov/pubmed/31601399
- Voulgaropoulou SD, van Amelsvoort TAMJ, Prickaerts J, Vingerhoets C (2019) The effect of curcumin on cognition in Alzheimer's disease and healthy aging: A systematic review of pre-clinical and clinical studies. Brain Res 1725:146476. - https://www.ncbi.nlm.nih.gov/pubmed/31560864
- Yang YSH, Li ZL, Shih YJ, Bennett JA, Whang-Peng J, Lin HY, Davis PJ, Wang K (2019) Herbal medicines attenuate PD-L1 expression to induce anti-proliferation in obesity-related cancers. Nutrients 11 pii: E2979. - https://www.ncbi.nlm.nih.gov/pubmed/31817534
- Rocha-Ferreira E, Sisa C, Bright S, Fautz T, Harris M, Contreras Riquelme I, Agwu C, Kurulday T, Mistry B, Hill D, Lange S, Hristova M (2019) Curcumin: novel treatment in neonatal hypoxic-ischemic brain injury. Front Physiol 10:1351. - https://www.ncbi.nlm.nih.gov/pubmed/31798458
- Feng D, Zou J, Su D, Mai H, Zhang S, Li P, Zheng X (2019) Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE-/- mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-ΞΊB inflammation. Nutr Metab (Lond) 16:79. - https://www.ncbi.nlm.nih.gov/pubmed/31788011
- Zhao Y, Chen B, Shen J, Wan L, Zhu Y, Yi T, Xiao Z (2017) The beneficial effects of Quercetin, Curcumin, and Resveratrol in obesity. Oxid Med Cell Longev 2017:1459497. - https://www.ncbi.nlm.nih.gov/pubmed/29138673
- Jin T, Song Z, Weng J, Fantus IG (2018) Curcumin and other dietary polyphenols: potential mechanisms of metabolic actions and therapy for diabetes and obesity. Am J Physiol Endocrinol Metab 314:E201-5. - https://www.ncbi.nlm.nih.gov/pubmed/29089337
- Tsuda T (2018) Curcumin as a functional food-derived factor: degradation products, metabolites, bioactivity, and future perspectives. Food Funct 9:705-14. - https://www.ncbi.nlm.nih.gov/pubmed/29206254
- Sanches-Silva A, Testai L, Nabavi SF, Battino M, Devi KP, Tejada S, Sureda A, Xu S, Yousefi B, Majidinia M, Russo GL, Efferth T, Nabavi SM, Farzaei MH (2020) Therapeutic potential of polyphenols in cardiovascular diseases: regulation of mTOR signaling pathway. Pharmacol Res. 2020 Jan 2:104626. - https://www.ncbi.nlm.nih.gov/pubmed/31904507
- Baziar N, Parohan M (2019) The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis of randomized controlled trials. Phytother Res. 2019 Dec 4. doi: 10.1002/ptr.6542. - https://www.ncbi.nlm.nih.gov/pubmed/31799714
- Saraf-Bank S, Ahmadi A, Paknahad Z, Maracy M, Nourian M (2019) Effects of curcumin on cardiovascular risk factors in obese and overweight adolescent girls: a randomized clinical trial. Sao Paulo Med J 2019 Nov 4. pii: S1516-31802019005008101. - https://www.ncbi.nlm.nih.gov/pubmed/31691723
- Fleenor BS, Carlini NA, Campbell MS (2019) Curcumin and arterial function in health and disease: impact on oxidative stress and inflammation. Curr Opin Clin Nutr Metab Care 22:459-64. - https://www.ncbi.nlm.nih.gov/pubmed/31577640
- Li H, Qi J, Li L (2019) Phytochemicals as potential candidates to combat obesity via adipose non-shivering thermogenesis. Pharmacol Res 147:104393. - https://www.ncbi.nlm.nih.gov/pubmed/31401211
MitoPedia: mitObesity drugs
Healthy reference population | Body mass excess | BFE | BME cutoffs | BMI | H | M | VO2max | mitObesity drugs |
MitoPedia concepts:
MiP concept
Labels:
MitoPedia:mitObesity drug